Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robin Reschke

Showing results (21-30 of 42) with videos related to

Pageof 5
Sort By:
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|January 25, 2021
Therapy understanding and health related quality of life in stage III/IV melanoma patients treated with novel adjuvant therapiesRobin Reschke, Iris Jäger, Anja Mehnert-Theuerkauf, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|September 21, 2019
Robin Reschke, Maja Mockenhaupt, Jan-Christoph Simon, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|June 19, 2019
Severe bullous skin eruptions on checkpoint inhibitor therapy - in most cases severe bullous lichenoid drug eruptionsRobin Reschke, Maja Mockenhaupt, Jan-Christoph Simon, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|February 15, 2021
Robin Reschke, Iris Jäger, Anja Mehnert-Theuerkauf, et al.
JAMA Dermatology|November 6, 2024
Use of Anti-PD1 Blockade After Hedgehog Inhibitors or as First-Line Therapy for Gorlin SyndromeRobin Reschke, Jasmin Richter, Alexander H Enk, et al.
Biomedicines|August 26, 2022
Effective Extracorporeal Photopheresis of Patients with Transplantation Induced Acute Intestinal GvHD and Bronchiolitis Obliterans SyndromeRobin Reschke, Stephanie Zimmerlich, Christine Döhring, et al.
Frontiers in Immunology|April 2, 2024
The role of tissue-resident memory T cells as mediators for response and toxicity in immunotherapy-treated melanoma-two sides of the same coin?Robin Reschke, Benjamin Deitert, Alex H Enk, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|February 18, 2020
Value of first-line surgical treatment for classic Kaposi sarcoma and potential use of checkpoint inhibitorsRobin Reschke, Sonja Grunewald, Monica Schüürmann, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|March 5, 2020
Robin Reschke, Sonja Grunewald, Monica Schüürmann, et al.
Cells|October 15, 2024
Immune Checkpoints and Cellular Landscape of the Tumor Microenvironment in Non-Melanoma Skin Cancer (NMSC)Ahmed M Mousa, Alexander H Enk, Jessica C Hassel, et al.
Pageof 5

Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|January 25, 2021
Therapy understanding and health related quality of life in stage III/IV melanoma patients treated with novel adjuvant therapiesRobin Reschke, Iris Jäger, Anja Mehnert-Theuerkauf, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|September 21, 2019
Robin Reschke, Maja Mockenhaupt, Jan-Christoph Simon, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|June 19, 2019
Severe bullous skin eruptions on checkpoint inhibitor therapy - in most cases severe bullous lichenoid drug eruptionsRobin Reschke, Maja Mockenhaupt, Jan-Christoph Simon, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|February 15, 2021
Robin Reschke, Iris Jäger, Anja Mehnert-Theuerkauf, et al.
JAMA Dermatology|November 6, 2024
Use of Anti-PD1 Blockade After Hedgehog Inhibitors or as First-Line Therapy for Gorlin SyndromeRobin Reschke, Jasmin Richter, Alexander H Enk, et al.
Biomedicines|August 26, 2022
Effective Extracorporeal Photopheresis of Patients with Transplantation Induced Acute Intestinal GvHD and Bronchiolitis Obliterans SyndromeRobin Reschke, Stephanie Zimmerlich, Christine Döhring, et al.
Frontiers in Immunology|April 2, 2024
The role of tissue-resident memory T cells as mediators for response and toxicity in immunotherapy-treated melanoma-two sides of the same coin?Robin Reschke, Benjamin Deitert, Alex H Enk, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|February 18, 2020
Value of first-line surgical treatment for classic Kaposi sarcoma and potential use of checkpoint inhibitorsRobin Reschke, Sonja Grunewald, Monica Schüürmann, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|March 5, 2020
Robin Reschke, Sonja Grunewald, Monica Schüürmann, et al.
Cells|October 15, 2024
Immune Checkpoints and Cellular Landscape of the Tumor Microenvironment in Non-Melanoma Skin Cancer (NMSC)Ahmed M Mousa, Alexander H Enk, Jessica C Hassel, et al.
Pageof 5